Boston Scientific
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Boston Scientific | |
|---|---|
| Image:Bostonscientificlogo.gif | |
| Type | Public () |
| Founded | 1979 |
| Headquarters | Natick, Massachusetts |
| Key people | John Abele, Founder & Director Peter Nicholas, Founder & Chairman James Tobin, CEO Paul LaViolette, COO |
| Industry | Medical Instruments & Supplies |
| Revenue | ▲$7.821 Billion USD (2006) |
| Net income | (Template:Loss$3.557 Billion) USD (2006) |
| Employees | 28,600 (2007) |
| Website | www.bostonscientific.com |
The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific is well known for the development of the Taxus Stent, a drug-coated stent which is used to open clogged arteries.
Boston Scientific's main competitors are Johnson & Johnson and Medtronic. The company recently acquired longtime competitor Guidant for approximately $28 billion. The former Guidant was split between BSC and Abbott Laboratories[1].
External links
- Boston Scientific official web site.
- Yahoo! - Boston Scientific Corporation Company Profile.
- Boston Scientific stock performance chart from GStock
- "Gamble wins big at Boston Scientific", boston.com.
Template:US-company-stubde:Boston Scientific nl:Boston Scientific
